MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$82,958K
EPS
-$2.46
Unit: Thousand (K) dollars

Income Statement
2026-03-31
Research and development
70,047
General and administrative
17,290
Total operating expenses
87,337
Loss from operations
-87,337
Interest income (expense), net
4,380
Other income (expense), net
-1
Net loss and comprehensive loss
-82,958
Net loss attributable to common stockholders
-82,958
Basic EPS
-2.46
Diluted EPS
-2.46
Basic Average Shares
33,700,550
Diluted Average Shares
33,700,550
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$82,958K Net loss andcomprehensive loss-$82,958K Interest income(expense), net$4,380K Loss from operations-$87,337K Other income(expense), net-$1K Total operatingexpenses$87,337K Research and development$70,047K General andadministrative$17,290K

Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics, Inc. (EIKN)